Takeda (ADR) (TAK)
Develops prescription medicines across gastrointestinal disease, rare disease, plasma therapies, oncology, neuroscience, and vaccines.
$18.89
After hours−0.06 (−0.34%)
At close$18.96(+0.34%)
Something off on this page? Send us feedback.
Next report
Oct 29, 26
in 37 days
EPS estimate
$0.15
Revenue estimate
$7.31B
Fiscal quarter
Q2 FY26
EPSReportedEstimate
Jan '25May '25Jul '25Oct '25Jan '26May '26Jul '26Oct '26
Reported$0.05−$0.22$0.52−$0.02$0.21−$0.05$0.23Pending
Estimate$0.34$0.24$0.47$0.44$0.55$0.21$0.17$0.15
Surprise−85.6%−193.5%+10.6%−105.7%−61.3%−123.4%+33.2%—
RevenueReportedEstimate
Jan '25May '25Jul '25Oct '25Jan '26May '26Jul '26Oct '26
Reported$7.39B$7.26B$7.35B$7.22B$7.73B$6.92B$7.66BPending
Estimate$7.36B$7.36B$8.02B$7.79B$7.54B$7.14B$7.13B$7.31B
Surprise+0.4%−1.2%−8.3%−7.3%+2.5%−3.0%+7.4%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Jun 2028 | $36.20 | — | — |
| Mar 2028 | $50.05 | — | — |
| Dec 2027 | $66.38 | — | — |
| Sep 2027 | $80.05 | — | — |
| Jun 2027 | $33.88 | — | — |
| Mar 2027 | −$11.70 | — | — |
| Dec 2026 | $23.86 | — | — |
| Oct 2026 | $0.15 | — | — |
| Jul 2026 | $0.17 | $0.23 | +33.2% |
| May 2026 | $0.21 | −$0.05 | −123.4% |
| Jan 2026 | $0.55 | $0.21 | −61.3% |
| Oct 2025 | $0.44 | −$0.02 | −105.7% |
| Jul 2025 | |||
| May 2025 | |||
| Jan 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Oct 2023 | |||
| Jul 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Oct 2022 | |||
| Jul 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| May 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Jun 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Jun 2028 | $36.20 | — | — | $1.14T | — | — | — |
| Mar 2028 | $50.05 | — | — | $1.11T | — | — | — |
| Dec 2027 | $66.38 | — | — | $1.17T | — | — | — |
| Sep 2027 | $80.05 | — | — | $1.14T | — | — | — |
| Jun 2027 | $33.88 | — | — | $1.13T | — | — | — |
| Mar 2027 | −$11.70 | — | — | $1.14T | — | — | — |
| Dec 2026 | $23.86 | — | — | $1.20T | — | — | — |
| Oct 29, 2026 | $0.15 | — | — | $7.31B | — | — | — |
| Jul 30, 2026 | $0.17 | $0.23 | +33.2% | $7.13B | $7.66B | +7.4% | −2.8% |
| May 13, 2026 | $0.21 | −$0.05 | −123.4% | $7.14B | $6.92B | −3.0% | +1.3% |
| Jan 29, 2026 | $0.55 | $0.21 | −61.3% | $7.54B | $7.73B | +2.5% | +2.9% |
| Oct 30, 2025 | $0.44 | −$0.02 | −105.7% | $7.79B | $7.22B | −7.3% | −3.9% |
| Jul 30, 2025 | |||||||
| May 8, 2025 | |||||||
| Jan 30, 2025 | |||||||
| Oct 31, 2024 | |||||||
| Jul 31, 2024 | |||||||
| May 9, 2024 | |||||||
| Feb 1, 2024 | |||||||
| Oct 26, 2023 | |||||||
| Jul 27, 2023 | |||||||
| May 11, 2023 | |||||||
| Feb 2, 2023 | |||||||
| Oct 27, 2022 | |||||||
| Jul 28, 2022 | |||||||
| May 11, 2022 | |||||||
| Feb 3, 2022 | |||||||
| Oct 28, 2021 | |||||||
| Jul 30, 2021 | |||||||
| May 11, 2021 | |||||||
| Feb 4, 2021 | |||||||
| Oct 29, 2020 | |||||||
| Jul 31, 2020 | |||||||
| May 13, 2020 | |||||||
| Feb 4, 2020 | |||||||
| Oct 31, 2019 | |||||||
| Jul 31, 2019 | |||||||
| May 14, 2019 | |||||||
| Feb 1, 2019 | |||||||
| Oct 31, 2018 | |||||||
| Jul 31, 2018 | |||||||
| May 14, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Sep 30, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Mar 31, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Sep 30, 2015 | |||||||
| Jun 30, 2015 |